Amneal Pharmaceuticals, Inc.
NYSE:AMRX
8.73 (USD) • At close November 8, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities: | ||||||||||
| Net Income
| -48.722 | -254.789 | 20.17 | 68.578 | -603.573 | -201.303 | 169.325 | 209.426 | 169.451 | 176.928 |
| Depreciation & Amortization
| 229.4 | 240.175 | 233.406 | 235.387 | 207.235 | 137.403 | 45.936 | 33.016 | 25.447 | 20.342 |
| Deferred Income Tax
| 94.339 | 0 | 83.389 | 95.644 | 371.716 | -9.439 | 0.742 | 0.121 | 0 | 0 |
| Stock Based Compensation
| 26.822 | 31.847 | 28.412 | 20.75 | 21.679 | 167.597 | 0 | 0 | 0 | 0 |
| Change In Working Capital
| -47.186 | -59.945 | -133.593 | -61.318 | -120.217 | 7.01 | -1.048 | -152.152 | -122.726 | -93.284 |
| Accounts Receivables
| 126.289 | -79.717 | -23.621 | 16.787 | -132.726 | 89.084 | 35.255 | -122.482 | -44.651 | -63.661 |
| Inventory
| -126.182 | -102.396 | -49.015 | -113.782 | -20.393 | -42.875 | -31.826 | -42.587 | -78.075 | -29.623 |
| Accounts Payables
| -94.446 | 109.568 | -43.932 | 0.307 | -10.257 | -55.212 | 18.105 | 6.265 | 0 | 0 |
| Other Working Capital
| 94.339 | 12.6 | -17.025 | 35.37 | 43.159 | 16.013 | -22.582 | 6.652 | 0 | 0 |
| Other Non Cash Items
| 90.924 | 107.812 | 10.036 | 19.96 | 124.865 | 148.962 | 14.52 | 3.252 | -90.015 | -85.013 |
| Operating Cash Flow
| 345.577 | 65.1 | 241.82 | 379.001 | 1.705 | 250.23 | 234.187 | 115.06 | 104.883 | 112.257 |
| Investing Activities: | ||||||||||
| Investments In Property Plant And Equipment
| -69.189 | -90.595 | -52.639 | -66.186 | -97.431 | -97.088 | -114.271 | -124.606 | -117.38 | -79.383 |
| Acquisitions Net
| 0 | -84.714 | -146.543 | -251.36 | 34.834 | -324.634 | 15.717 | 0 | 0 | 0 |
| Purchases Of Investments
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Sales Maturities Of Investments
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Investing Activites
| -25.973 | 1 | 5 | -255.71 | 43.017 | 25.344 | -3.783 | -1.85 | -18.244 | -41.598 |
| Investing Cash Flow
| -69.189 | -174.309 | -194.182 | -317.546 | -19.58 | -396.378 | -98.554 | -124.606 | -135.624 | -120.981 |
| Financing Activities: | ||||||||||
| Debt Repayment
| -414.08 | -123.272 | -79.179 | -37.012 | -29.27 | -784.336 | -13.899 | -36.396 | -13.011 | -39.732 |
| Common Stock Issued
| 0 | 0.662 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Common Stock Repurchased
| -2.378 | -3.571 | -2.664 | -0.863 | -0.926 | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid
| 0 | 0 | 0 | 0 | 0 | -182.998 | -375.265 | -200.615 | -258.169 | -243 |
| Other Financing Activities
| 201.507 | 23.132 | -56.279 | 169.682 | -15.637 | 1,255.009 | 294.149 | 217.516 | 233.182 | 291.067 |
| Financing Cash Flow
| -212.573 | -106.62 | -138.122 | 131.807 | -45.833 | 287.675 | -95.015 | -19.495 | -24.987 | 48.067 |
| Other Information: | ||||||||||
| Effect Of Forex Changes On Cash
| 0.065 | -5.683 | 0.102 | 1.037 | -2.249 | -0.67 | -0.242 | 1.481 | -0.707 | -3.706 |
| Net Change In Cash
| 63.88 | -221.512 | -90.382 | 194.299 | -65.957 | 140.857 | 40.376 | -27.56 | -56.435 | 35.637 |
| Cash At End Of Period
| 99.107 | 35.227 | 256.739 | 347.121 | 152.822 | 218.779 | 77.922 | 37.546 | 61.087 | 117.522 |